Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1148118

registered interest
date	03/10/2019
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Tibet: Climate Change
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, what discussions he has had with his Chinese counterpart on the effect of climate change on Tibet.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	294242
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>“It has not proved possible to respond to the hon. Member in the time available before Prorogation.”</p><p> </p> answering member constituency South Derbyshire answering member printed Mrs Heather Wheeler question first answered 08/10/2019 13:52:15 answering member 4053 label Biography information for Mrs Heather Wheeler
tabling member	4131 label Biography information for Jim Shannon

1148119

registered interest
date	03/10/2019
answering body	Department for International Trade
answering dept id	202
answering dept short name	International Trade
answering dept sort name	International Trade
hansard heading	Foreign Investment in UK
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Trade, what guidance his Department issues to foreign companies planning to invest in the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	294168
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department for International Trade (DIT) plays a critical role in promoting the UK as the natural choice for overseas investment. The Department provides support to inward investors who wish to set up in the UK.</p><p> </p><p>These services range from providing information, guidance and support on the UK business environment, to access to finance, talent and skills, visas and migration, research and innovation, and sector experts.</p><p> </p><p>DIT also provides an end-to-end service for investors, through initiatives such as the Strategic Relationship Management Programme, both in the UK and overseas, working with colleagues across government, in London, UK regions and Devolved Administrations. This suite of services helps investors prosper and succeed, which in turn leads them to reinvest further in the UK. The UK has the highest stock of FDI of any nation in Europe.</p><p> </p> answering member constituency Beverley and Holderness answering member printed Graham Stuart question first answered 08/10/2019 16:13:00 answering member 1482 label Biography information for Graham Stuart
tabling member	4131 label Biography information for Jim Shannon

1148120

registered interest
date	03/10/2019
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Armed Forces: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, what steps he is taking to ensure the safety of recruits undertaking physical training courses.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	294169
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>We take our duty of care to our personnel very seriously, but risk is inherent in many activities carried out by the Armed Forces. This risk is rendered as low as reasonably practicable during training by ensuring that its design and delivery are subject to strict safety procedures and rigorous risk analysis. Training programmes are also subject to internal or external assurance and audit inspections including by OFSTED.</p><p>On 1 April 2015, we established the Defence Safety Authority which brings together the Defence Safety Regulators and the Accident Investigation Branch, providing independent assurance to the Secretary of State in accordance with his health, safety and environmental policy statement.</p> answering member constituency Plymouth, Moor View answering member printed Johnny Mercer question first answered 08/10/2019 13:31:33 answering member 4485 label Biography information for Johnny Mercer
tabling member	4131 label Biography information for Jim Shannon

1148121

registered interest
date	03/10/2019
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Armed Forces: Sick Leave
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, what estimate he has made of level of sickness absence among women in the armed forces in the latest period for which figures are available.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	294243
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Ministry of Defence (MOD) takes the health and wellbeing of its personnel very seriously. A Health and Wellbeing Strategy for all MOD employees, military and civilian, was published in mid-2015 (updated in August 2016) and is designed to provide guidance to the Chain of Command and civilian line managers on how to manage the health needs, both mental and physical, of their people. The aim is to maximise the number of people fit to work, managing people back to work after a period of sickness, so that they are fit and able to meet the requirements of Defence outputs, including operational effectiveness.</p><p>Whilst the MOD records the medical employability and deployability of Service personnel, more specific information about the level of sickness absence among women - or men - in the Armed Forces is not held centrally. As at 1 May 2019, medical employability for the trained UK Armed Forces was 98 per cent, with a male:female split of 98:97% respectively.</p> answering member constituency Plymouth, Moor View answering member printed Johnny Mercer question first answered 08/10/2019 12:57:21 answering member 4485 label Biography information for Johnny Mercer
tabling member	4131 label Biography information for Jim Shannon

1148122

registered interest
date	03/10/2019
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Birds: Pest Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment she has made of the effectiveness of the general licences for bird control that were introduced in April 2019.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	294170
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Richmond Park answering member printed Zac Goldsmith question first answered 08/10/2019 16:31:31 answering member 4062 label Biography information for Lord Goldsmith of Richmond Park
tabling member	4131 label Biography information for Jim Shannon

1148207

registered interest
date	03/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Parkinson's Disease: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with health bodies on the findings of recent clinical trials for Terazosin and its potential effect of slowing down the progression of Parkinson's disease.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	294171
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 08/10/2019 15:21:50 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1148209

registered interest
date	03/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Montelukast: Side Effects
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of reports that doctors have been advised to warn asthma patients using the drug Montelukast of potential hallucinations and suicidal thoughts and other side-effects.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	294172
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>Montelukast is effective in the treatment of asthma in adults, adolescents and children aged six months and older who are not adequately controlled on their usual/routine asthma medication and who need additional therapy. Montelukast also helps to prevent the narrowing of airways triggered by exercise. The benefits of montelukast have been shown to outweigh the risks in adults and children.</p><p>The very rare risk (up to 1 in 10,000 people) of neuropsychiatric reactions in association with montelukast treatment has been known for some time and information about adverse reactions including hallucinations and suicidal thinking and behaviour (suicidality) are already included in the product information for montelukast.</p><p>In September the Medicines and Healthcare Products Regulatory Agency published an article in Drug Safety Update to remind prescribers of the very rare risk of neuropsychiatric reactions with use of montelukast. The article outlines the risks and advises healthcare professionals to evaluate carefully the risks and benefits of continuing treatment with montelukast if neuropsychiatric reactions occur. Healthcare professionals are reminded to report any suspected adverse drug reactions associated with montelukast to the Yellow Card Scheme.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 08/10/2019 15:07:26 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4131 label Biography information for Jim Shannon

1148211

registered interest
date	03/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Stargardt Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people were diagnosed with Stargardt Disease in the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	294173
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 08/10/2019 15:19:26 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1148212

registered interest
date	03/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Glaucoma: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to make the biodegradable implant that replaces eye drops for glaucoma available on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	294174
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>Decisions about treatment should always be based on patients’ clinical needs. Clinical commissioning groups (CCGs) are required to commission healthcare services that meet the needs of their local population. To achieve this, they must assess local need, determining priorities and strategies, and commission services on behalf of their local population; overseeing those contracts to ensure high-quality care is provided.</p><p>National Health Service commissioners are legally required to fund treatments recommended in National Institute for Health and Care Excellence technology appraisal and highly specialised technologies guidance.</p><p>The future routine availability of any new or novel treatments would be subject to large scale clinical trials demonstrating the safety and efficacy of the treatment approach and subsequent assessments of its cost effectiveness for routine use.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 08/10/2019 14:46:07 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1148214

registered interest
date	03/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to improve diagnostic rates of the NHS bowel cancer test.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	294175
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Government committed in the NHS Long Term Plan published in January to modernise the Bowel Cancer Screening Programme (BCSP) to detect more cancers earlier. The plan will modernise the BCSP to detect more cancers earlier by lowering the starting age for bowel screening from 60 to 50.</p><p>Further, the Faecal Immunochemical Test was rolled out in England in June 2019 following a UK National Screening Committee recommendation to replace the previously used Faecal Occult Blood test. This test is both more accurate and more acceptable so will contribute to saving many more lives from bowel cancer and, as an easier test for patients to use, is expected to improve take up rates by 7%, including among groups with low participation rates such as men, people from ethnic minority backgrounds and people in more deprived areas.</p><p>In addition, we expect the Professor Sir Mike Richards’ Review of Screening, due to be published soon, to identify additional opportunities to improve the uptake of bowel cancer screening.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 08/10/2019 14:49:34 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon